Caxton Associates LLP Makes New $394,000 Investment in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Caxton Associates LLP has acquired a new position in Acadia Healthcare Company, purchasing 13,000 shares valued at approximately $394,000 in the first quarter.
• Several institutional investors have significantly increased their stakes in Acadia Healthcare, with Hawk Ridge Capital raising its position by 437.5% and Citigroup increasing its position by 5,144.2% during the same period.
• Acadia Healthcare has received mixed analyst ratings, with price targets adjusted downwards, suggesting a consensus rating of "Moderate Buy" and an average target price of $39.00.

Caxton Associates LLP acquired a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 13,000 shares of the company's stock, valued at approximately $394,000.

Several other hedge funds also recently added to or reduced their stakes in the stock. Goldman Sachs Group Inc. grew its holdings in Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company's stock worth $21,170,000 after acquiring an additional 121,444 shares in the last quarter. Silver Rock Financial LP acquired a new position in Acadia Healthcare during the 1st quarter worth $9,399,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Acadia Healthcare during the 1st quarter worth $1,600,000. Invenomic Capital Management LP acquired a new position in Acadia Healthcare during the 1st quarter worth $2,176,000. Finally, Josh Arnold Investment Consultant LLC acquired a new position in Acadia Healthcare during the 1st quarter worth $1,334,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. Bank of America downgraded shares of Acadia Healthcare from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $27.00 to $25.00 in a research report on Wednesday, September 10th. Guggenheim reduced their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Cowen restated a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Royal Bank Of Canada reduced their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. Finally, UBS Group reduced their price target on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $39.00.

Acadia Healthcare Stock Performance

NASDAQ:ACHC traded up $0.15 during mid-day trading on Thursday, hitting $22.07. The stock had a trading volume of 2,257,779 shares, compared to its average volume of 2,359,894. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of 14.62, a P/E/G ratio of 4.31 and a beta of 0.89. The company has a 50 day simple moving average of $21.90 and a 200-day simple moving average of $23.92. Acadia Healthcare Company, Inc. has a 52 week low of $17.13 and a 52 week high of $78.35. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.